Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease

10.1002/hep.29811 ◽

2018 ◽

Vol 68 (3) ◽

pp. 827-838 ◽

Author(s):

Lisa I. Backus ◽

Pamela S. Belperio ◽

Troy A. Shahoumian ◽

Larry A. Mole

Keyword(s):

Liver Disease ◽

Sustained Virologic Response ◽

Virologic Response ◽

Advanced Liver Disease ◽

Direct Acting Antiviral ◽

Download Full-text

Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease

10.1002/hep.29408 ◽

2018 ◽

Vol 69 (2) ◽

pp. 487-497 ◽

Author(s):

Lisa I. Backus ◽

Pamela S. Belperio ◽

Troy A. Shahoumian ◽

Larry A. Mole

Keyword(s):

Liver Disease ◽

Sustained Virologic Response ◽

Antiviral Treatment ◽

Virologic Response ◽

Advanced Liver Disease ◽

Direct Acting Antiviral ◽

Download Full-text

Current Status of Hepatocellular Carcinoma Occurrence after Achieving a Sustained Virologic Response with Direct-Acting Antiviral Drug Treatment for Type C Chronic Liver Disease: A Study at Kawasaki Municipal Tama Hospital

Journal of St Marianna University ◽

10.17264/stmarieng.11.143 ◽

2020 ◽

Vol 11 (2) ◽

pp. 143-152

Author(s):

Kotaro Matsunaga ◽

Chiaki Okuse ◽

Sarika Nakamura ◽

Keigo Suetani ◽

Shinya Ishigooka ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Liver Disease ◽

Drug Treatment ◽

Sustained Virologic Response ◽

Antiviral Drug ◽

Virologic Response ◽

Current Status ◽

Direct Acting Antiviral ◽

Type C ◽

Download Full-text

Influence of Proton Pump Inhibitors and H2 Receptor Antagonists on Direct Acting Antiviral HCV Sustained Virologic Response

Journal of Hepatology ◽

10.1016/s0168-8278(16)01540-3 ◽

2016 ◽

Vol 64 (2) ◽

pp. S790 ◽

Author(s):

L. DeVreese ◽

P. Giguère ◽

D. Corsi ◽

C. Cooper

Keyword(s):

Proton Pump Inhibitors ◽

Proton Pump ◽

Sustained Virologic Response ◽

Virologic Response ◽

Receptor Antagonists ◽

H2 Receptor Antagonists ◽

H2 Receptor ◽

Direct Acting Antiviral ◽

Download Full-text

Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy

Open Forum Infectious Diseases ◽

10.1093/ofid/ofaa569 ◽

2020 ◽

Vol 7 (12) ◽

Author(s):

Alicia B Carver ◽

Autumn D Zuckerman ◽

Joshua DeClercq ◽

Leena Choi ◽

Cody A Chastain

Keyword(s):

Antiviral Therapy ◽

Sustained Virologic Response ◽

Response Rates ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Rapid Virologic Response ◽

Persistent Viremia ◽

Direct Acting ◽

High Sustained Virologic Response

Abstract Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.

Download Full-text

DI-062 Sustained virologic response rates of new direct acting antiviral agents for HCV

European Journal of Hospital Pharmacy ◽

10.1136/ejhpharm-2016-000875.328 ◽

2016 ◽

Vol 23 (Suppl 1) ◽

pp. A145.2-A146

Author(s):

C Caballero Requejo ◽

M Onteniente Candela ◽

JJ Franco Miguel ◽

M Garcia Coronel ◽

A Trujillano Ruiz ◽

...

Keyword(s):

Sustained Virologic Response ◽

Antiviral Agents ◽

Response Rates ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Direct Acting Antiviral Agents

Download Full-text

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease

Medicine ◽

10.1097/md.0000000000006128 ◽

2017 ◽

Vol 96 (6) ◽

pp. e6128 ◽

Author(s):

Christine Y. Chang ◽

Pauline Nguyen ◽

An Le ◽

Changqing Zhao ◽

Aijaz Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Liver Disease ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Asian Americans ◽

Advanced Liver Disease ◽

Direct Acting Antiviral ◽

Antiviral Therapies ◽

Download Full-text

Sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for treating patients with hepatitis C virus reinfection following direct‐acting antiviral‐induced sustained virologic response

Advances in Digestive Medicine ◽

10.1002/aid2.13302 ◽

2021 ◽

Author(s):

Chen‐Hua Liu ◽

Chun‐Jen Liu ◽

Tung‐Hung Su ◽

Tai‐Chung Tseng ◽

Pei‐Jer Chen ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Download Full-text

HCV genotype 4, 5 and 6: Distribution of viral subtypes and sustained virologic response rates in clinical trials of approved direct-acting antiviral regimens

Journal of Viral Hepatitis ◽

10.1111/jvh.12896 ◽

2018 ◽

Vol 25 (8) ◽

pp. 969-975 ◽

Author(s):

S. D. Boyd ◽

P. Harrington ◽

T. E. Komatsu ◽

L. K. Naeger ◽

K. Chan-Tack ◽

...

Keyword(s):

Clinical Trials ◽

Sustained Virologic Response ◽

Response Rates ◽

Virologic Response ◽

Hcv Genotype ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Download Full-text

Hepatitis C “true” late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy

Journal of Hepatology ◽

10.1016/j.jhep.2017.01.002 ◽

2017 ◽

Vol 66 (4) ◽

pp. 862-863 ◽

Author(s):

Thomas Klag ◽

Julia Dietz ◽

Christoph R. Werner ◽

Julia M. Schwarz ◽

Ulrich M. Lauer ◽

...

Keyword(s):

Hepatitis C ◽

Antiviral Therapy ◽

Sustained Virologic Response ◽

Virologic Response ◽

Late Relapse ◽

Direct Acting Antiviral ◽

Download Full-text

Short‐term histological evaluations after achieving a sustained virologic response to direct‐acting antiviral treatment for chronic hepatitis C

United European Gastroenterology Journal ◽

10.1177/2050640618791053 ◽

2018 ◽

Vol 6 (9) ◽

pp. 1391-1400 ◽

Author(s):

Masaru Enomoto ◽

Yoshihiro Ikura ◽

Akihiro Tamori ◽

Ritsuzo Kozuka ◽

Hiroyuki Motoyama ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Antiviral Treatment ◽

Virologic Response ◽

Direct Acting Antiviral ◽

Download Full-text